表紙
市場調査レポート

歯科用バイオマテリアル:パイプライン分析

Dental Biomaterials - Pipeline Review, 2015

発行 GlobalData 商品コード 344642
出版日 ページ情報 英文 80 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
歯科用バイオマテリアル:パイプライン分析 Dental Biomaterials - Pipeline Review, 2015
出版日: 2015年10月01日 ページ情報: 英文 80 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の、歯科用バイオマテリアル (生体材料) のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・分野別・地域別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発の動き・業界動向などを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:分野別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 歯科用バイオマテリアル:現在開発中のパイプライン製品 (企業別)

  • 歯科用バイオマテリアルの開発企業:パイプライン製品 (開発段階別)
  • 歯科用バイオマテリアル:開発段階別のパイプライン製品の一覧

第5章 歯科用バイオマテリアルの企業・製品の概要

  • スリー・ディー・マトリックス
    • パイプライン製品および現在進行中の治験の概要
  • Advanced Medical Solutions Group plc
  • botiss dental GmbH
  • CollPlant Ltd.
  • CoreBone Ltd.
  • Harvard University
  • Histocell S.L.
  • Ironwood Material Science Inc
  • Lacerta Technologies GmbH
  • Maxigen Biotech Inc.
  • Medisse BV
  • Medtronic plc
  • Meta Biomed Co., Ltd.
  • NDSU Research Foundation
  • Noraker
  • NovaBone Products, LLC.
  • Novatissue SAS
  • REGENECURE, Ltd.
  • Straumann Holding AG
  • SurgaColl Technologies Ltd
  • The University of Queensland
  • Tigran Technologies AB
  • Universitat Politecnica de Catalunya
  • University of Strasbourg

第6章 歯科用バイオマテリアル:昨今の市場動向

第7章 付録

図表一覧

目次
Product Code: GDME0093EPD

GlobalData's Medical Devices sector report, "Dental Biomaterials - Pipeline Review, 2015" provides an overview of Dental Biomaterials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dental Biomaterials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Dental Biomaterials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dental Biomaterials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dental Biomaterials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Dental Biomaterials Overview

3. Products under Development

  • 3.1. Dental Biomaterials - Pipeline Products by Stage of Development
  • 3.2. Dental Biomaterials - Pipeline Products by Segment
  • 3.3. Dental Biomaterials - Pipeline Products by Territory
  • 3.4. Dental Biomaterials - Pipeline Products by Regulatory Path
  • 3.5. Dental Biomaterials - Pipeline Products by Estimated Approval Date
  • 3.6. Dental Biomaterials - Ongoing Clinical Trials

4. Dental Biomaterials - Pipeline Products under Development by Companies

  • 4.1. Dental Biomaterials Companies - Pipeline Products by Stage of Development
  • 4.2. Dental Biomaterials - Pipeline Products by Stage of Development

5. Dental Biomaterials Companies and Product Overview

  • 5.1. 3-D Matrix, Ltd. Company Overview
    • 5.1.1. 3-D Matrix, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Advanced Medical Solutions Group plc Company Overview
    • 5.2.1. Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. botiss dental GmbH Company Overview
    • 5.3.1. botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. CollPlant Ltd. Company Overview
    • 5.4.1. CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. CoreBone Ltd. Company Overview
    • 5.5.1. CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Harvard University Company Overview
    • 5.6.1. Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Histocell S.L. Company Overview
    • 5.7.1. Histocell S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Ironwood Material Science Inc Company Overview
    • 5.8.1. Ironwood Material Science Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Lacerta Technologies GmbH Company Overview
    • 5.9.1. Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Maxigen Biotech Inc. Company Overview
    • 5.10.1. Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Medisse BV Company Overview
    • 5.11.1. Medisse BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Medtronic plc Company Overview
    • 5.12.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Meta Biomed Co., Ltd. Company Overview
    • 5.13.1. Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. NDSU Research Foundation Company Overview
    • 5.14.1. NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Noraker Company Overview
    • 5.15.1. Noraker Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. NovaBone Products, LLC. Company Overview
    • 5.16.1. NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Novatissue SAS Company Overview
    • 5.17.1. Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. REGENECURE, Ltd. Company Overview
    • 5.18.1. REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Straumann Holding AG Company Overview
    • 5.19.1. Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. SurgaColl Technologies Ltd Company Overview
    • 5.20.1. SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. The University of Queensland Company Overview
    • 5.21.1. The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Tigran Technologies AB Company Overview
    • 5.22.1. Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Universitat Politecnica de Catalunya Company Overview
    • 5.23.1. Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. University of Strasbourg Company Overview
    • 5.24.1. University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview

6. Dental Biomaterials- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Dental Biomaterials - Pipeline Products by Stage of Development
  • Table 2: Dental Biomaterials - Pipeline Products by Segment
  • Table 3: Dental Biomaterials - Pipeline Products by Territory
  • Table 4: Dental Biomaterials - Pipeline Products by Regulatory Path
  • Table 5: Dental Biomaterials - Pipeline Products by Estimated Approval Date
  • Table 6: Dental Biomaterials - Ongoing Clinical Trials
  • Table 7: Dental Biomaterials Companies - Pipeline Products by Stage of Development
  • Table 8: Dental Biomaterials - Pipeline Products by Stage of Development
  • Table 9: 3-D Matrix, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: TDM-711 - Product Status
  • Table 11: TDM-711 - Product Description
  • Table 12: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: PARASORB Cone - Product Status
  • Table 14: PARASORB Cone - Product Description
  • Table 15: PARASORB Cone Genta - Product Status
  • Table 16: PARASORB Cone Genta - Product Description
  • Table 17: PARASORB Fleece - Product Status
  • Table 18: PARASORB Fleece - Product Description
  • Table 19: PARASORB Fleece Genta HD - Product Status
  • Table 20: PARASORB Fleece Genta HD - Product Description
  • Table 21: PARASORB Fleece HD - Product Status
  • Table 22: PARASORB Fleece HD - Product Description
  • Table 23: PARASORB RESODONT - Product Status
  • Table 24: PARASORB RESODONT - Product Description
  • Table 25: PARASORB Sombrero - Product Status
  • Table 26: PARASORB Sombrero - Product Description
  • Table 27: botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: cerabone - Product Status
  • Table 29: cerabone - Product Description
  • Table 30: maxresorb - Product Status
  • Table 31: maxresorb - Product Description
  • Table 32: maxresorb Inject - Product Status
  • Table 33: maxresorb Inject - Product Description
  • Table 34: mucoderm - Product Status
  • Table 35: mucoderm - Product Description
  • Table 36: perossal - Product Status
  • Table 37: perossal - Product Description
  • Table 38: CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: VergenixAR - Product Status
  • Table 40: VergenixAR - Product Description
  • Table 41: CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Dental Bone Graft - Product Status
  • Table 43: Dental Bone Graft - Product Description
  • Table 44: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Artificial Teeth - Product Status
  • Table 46: Artificial Teeth - Product Description
  • Table 47: Histocell S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Neofibrin - Product Status
  • Table 49: Neofibrin - Product Description
  • Table 50: Ironwood Material Science Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: GEMOSIL - Dental Implant - Product Status
  • Table 52: GEMOSIL - Dental Implant - Product Description
  • Table 53: Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Albumin Bone Graft - Product Status
  • Table 55: Albumin Bone Graft - Product Description
  • Table 56: Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: MaxiBone - Product Status
  • Table 58: MaxiBone - Product Description
  • Table 59: MaxiGuide - Product Status
  • Table 60: MaxiGuide - Product Description
  • Table 61: Medisse BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Dental Membrane - Product Status
  • Table 63: Dental Membrane - Product Description
  • Table 64: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: MD05-P Bone Graft Substitute Material - Product Status
  • Table 66: MD05-P Bone Graft Substitute Material - Product Description
  • Table 67: MD08 Injectable Paste - Product Status
  • Table 68: MD08 Injectable Paste - Product Description
  • Table 69: Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Biocompatible Sealer - Product Status
  • Table 71: Biocompatible Sealer - Product Description
  • Table 72: Endodontic Sealer - Product Status
  • Table 73: Endodontic Sealer - Product Description
  • Table 74: Root Canal Sealer - Product Status
  • Table 75: Root Canal Sealer - Product Description
  • Table 76: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Synthetic Mandible - Product Status
  • Table 78: Synthetic Mandible - Product Description
  • Table 79: Noraker Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: Bone Grafting Device - Dental Surgery - Product Status
  • Table 81: Bone Grafting Device - Dental Surgery - Product Description
  • Table 82: Self-Hardening Injectable Substitute - Dental Surgery - Product Status
  • Table 83: Self-Hardening Injectable Substitute - Dental Surgery - Product Description
  • Table 84: NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Bioengineered Resorbable Bone Graft - Dental - Product Status
  • Table 86: Bioengineered Resorbable Bone Graft - Dental - Product Description
  • Table 87: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: Dental NovaOss - Product Status
  • Table 89: Dental NovaOss - Product Description
  • Table 90: REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Regenecure AMCA GBR Dental Membrane Implant - Product Status
  • Table 92: Regenecure AMCA GBR Dental Membrane Implant - Product Description
  • Table 93: REGENECURE, Ltd. - Ongoing Clinical Trials Overview
  • Table 94: Regenecure AMCA GBR Dental Membrane Implant - Horizontal Guided Bone Regeneration for Dental Implants Using Synthetic Membrane (Regenecures' AMCA GBR Dental Membrane) a Prospective Controlled Study
  • Table 95: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 96: Enhanced Bone Graft - Product Status
  • Table 97: Enhanced Bone Graft - Product Description
  • Table 98: Soft Tissue Control Implant - Product Status
  • Table 99: Soft Tissue Control Implant - Product Description
  • Table 100: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: DentaColl - Product Status
  • Table 102: DentaColl - Product Description
  • Table 103: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: Dental Material - Product Status
  • Table 105: Dental Material - Product Description
  • Table 106: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 107: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status
  • Table 108: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description
  • Table 109: Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Inorganic Dental Cement - Product Status
  • Table 111: Inorganic Dental Cement - Product Description
  • Table 112: University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Nanostructured Biomaterial - Product Status
  • Table 114: Nanostructured Biomaterial - Product Description
  • Table 115: Glossary

List of Figures

  • Figure 1: Dental Biomaterials - Pipeline Products by Stage of Development
  • Figure 2: Dental Biomaterials - Pipeline Products by Segment
  • Figure 3: Dental Biomaterials - Pipeline Products by Territory
  • Figure 4: Dental Biomaterials - Pipeline Products by Regulatory Path
  • Figure 5: Dental Biomaterials - Pipeline Products by Estimated Approval Date
  • Figure 6: Dental Biomaterials - Ongoing Clinical Trials
Back to Top